ARTV in the 13F filings

Artiva Biotherapeutics Inc · CUSIP 04317A107

Q3 2026: 47 of 95 managers have filed so far; the filing deadline was 16 November 2026. Its figures cover those filers only, so it is not yet a picture of the tracked managers.

Quarter end
30 Sep 2026
the date the book describes
Filed
16 Nov 2026
latest of these filings; the earliest 9 Nov 2026
Managers listing it
13
at least, of 95 tracked, among listed positions
Comparable managers
46
filed both Q2 2026 and Q3 2026; 1 listed it in both
Shares listed
3,454,241
combined, among listed positions
Reported value
$25m
combined, at the quarter end

Among the 89 comparable managers: 7 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -238,317.

Managers listing ARTV in Q3 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2026, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

13 of 13 holders

Largest increases and reductions, by shares

Q2 2026 to Q3 2026, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
2 in Q3 2024 to 1 in Q3 2026

Tracked managers listing it, at least.

01122Q3 2024Q4 2024Q2 2026Q3 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ARTV by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20242$19m20
Q4 20241$9.2m00
Q2 20261$25m73
Q3 20261$19m73

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ARTV and GILD →ARTV and AMGN →ARTV and MRNA →Choose a stock to compare with ARTV →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ARTV, latest filings →Back to the 13F Explorer →